pH Associates: European joint working in the evaluation of the Infliximab Paediatric Crohn's Disease Education Plan

Date: 2/6/2010

pH Associates, working in partnership with contemporaries across Europe have recently completed a multi-centre, cross sectional evaluation of the Infliximab Paediatric Crohn's Disease Educational Plan. Findings of the evaluation are published this week in Drug Safety (Drug safety 2010; 33 (6) pages: 489 - 501).